| Jun 6 |
Structure Therapeutics announces pricing of upsized $476M securities offering at $52.50/ADS
|
| Jun 5 |
Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering
|
| Jun 5 |
Structure Therapeutics' Slim Obesity Hopes In A Pill Take Shape
|
| Jun 4 |
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
|
| Jun 4 |
Heard on the Street Monday Recap: Catnip
|
| Jun 3 |
Structure Therapeutics announces proposed public offering of American depositary shares and pre-funded warrants
|
| Jun 3 |
Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants
|
| Jun 3 |
Structure Therapeutics' Obesity Candidate Is ' Very Competitive' To Eli Lilly's Orforglipron, Analyst Says
|
| Jun 3 |
Top Midday Gainers
|
| Jun 3 |
Structure Therapeutics Stock Skyrockets To Six-Month High On Compelling Weight-Loss Drug Results
|
